Language:

Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1278-1287 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;ISSN: 0268-3369 ;EISSN: 1476-5365 ;DOI: 10.1038/s41409-018-0155-z ;PMID: 29581480

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation
Author: Duncan, Christine N ; Brazauskas, Ruta ; Huang, Jiaxing ; Shaw, Bronwen E ; Majhail, Navneet S ; Savani, Bipin N ; Flowers, Mary E D ; Battiwalla, Minoo ; Beebe, Kristen ; Dietz, Andrew C ; Dvorak, Christopher C ; Giller, Roger ; Jacobsohn, David A ; Kletzel, Morris ; Martin, Paul L ; Nemecek, Eneida R ; Nuechterlein, Brandon ; Talano, Julie-An ; Pulsipher, Michael A ; Baker, K Scott
Subjects: Adolescent ; Adult ; Allografts ; Anthracycline ; Anthracyclines ; Body mass ; Body weight ; Bone marrow transplantation ; Cancer ; Cancer treatment ; Cardiomyopathy ; Cardiotoxicity ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - mortality ; Cardiovascular Diseases - therapy ; Chemotherapy ; Chest ; Child ; Child, Preschool ; Children ; Combined Modality Therapy ; Complications ; Complications and side effects ; Coronary artery ; Coronary artery disease ; Coronary heart disease ; Death ; Diabetes mellitus ; Disease-Free Survival ; Dyslipidemia ; Female ; Follow-Up Studies ; Forecasts and trends ; Health risk assessment ; Health risks ; Heart diseases ; Hematologic Neoplasms - blood ; Hematologic Neoplasms - mortality ; Hematologic Neoplasms - therapy ; Hematopoietic Stem Cell Transplantation ; Hematopoietic stem cells ; Hemopoiesis ; Humans ; Incidence ; Male ; Malignancy ; Medical research ; Medical schools ; Morbidity ; Mortality ; Myocardial diseases ; Obesity ; Obesity - blood ; Obesity - mortality ; Obesity - therapy ; Patients ; Pediatrics ; Radiation ; Radiation (Physics) ; Retrospective Studies ; Risk analysis ; Risk Factors ; Severity of Illness Index ; Stroke ; Surgery ; Survival Rate ; Transplantation ; Transplants & implants
Is Part Of: Bone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1278-1287
Description: We analyzed late cardiovascular outcomes of 661 patients who survived at least 2 years from hematopoietic cell transplantation for childhood hematologic malignancy between 1995 and 2008. Center for International Blood and Marrow Transplant Research data was supplemented with surveys focused on cardiotoxicity and potential risk factors. The median duration of follow-up was 97 months (range 24-230). 4.2% of survivors experienced at least one of the primary outcomes including coronary artery disease (0.2%), cerebrovascular accident (0.6%), cardiomyopathy (3%), and cardiac-related death (0.5%). Patients who received anthracycline chemotherapy (HR 4.67, p = 0.036) or cranial or chest radiation (HR 5.58, p < 0.0001; HR 2.18, p = 0.0087) were at increased risk for developing one of the primary outcomes. Dyslipidemia was diagnosed in 18% of survivors. Pre-transplant anthracycline (HR 1.74, p < 0.0001) and chest radiation (HR 1.34, p = 0.0371) were risk factors for dyslipidemia. Overweight/obese body mass status was present in 63% of patients at baseline, 65% at 2 years, and 52% at most recent evaluation. Diabetes was diagnosed in 7% of subjects. In conclusion, severe cardiovascular complications were infrequently reported. The incidence of risk factors including obesity and dyslipidemia were significant and will likely increase the risk of cardiovascular disease over time in transplant survivors.
Publisher: England: Nature Publishing Group
Language: English
Identifier: ISSN: 0268-3369
EISSN: 1476-5365
DOI: 10.1038/s41409-018-0155-z
PMID: 29581480
Source: GFMER Free Medical Journals
MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;ISSN: 0268-3369 ;EISSN: 1476-5365 ;DOI: 10.1038/s41409-018-0155-z ;PMID: 29581480

Searching Remote Databases, Please Wait